3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| STM2457 | 2499663-01-1 | |
| Batabulin | Unii-T4np8G3K6q | 195533-53-0 |
| MK-8745 | MK8745 | 885325-71-3 |
| S65487 | S-65487 | 1644600-79-2 |
| (S)-Thalidomide | (-)-沙利度胺 | 841-67-8 |
| BAM7 | 331244-89-4 | |
| Devimistat | 6,8-双(苄硫基)辛酸 | 95809-78-2 |
| CVT-11127 | N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 | 1018674-83-3 |
| LCS-1 | 4,5-二氯-2-(3-甲苯基)哒嗪-3-酮 | 41931-13-9 |
| BCL6-IN-7 | 化合物 T8731 | 2097518-46-0 |
| T-1101 tosylate | TAI-95 tosylate | 2250404-95-4 |
| TVB-3166 | 1533438-83-3 | |
| A-1210477 | 1668553-26-1 | |
| ISRIB (trans-isomer) | ISRIB(TRANS-ISOMER) 抑制剂 | 1597403-47-8 |
| Pyridoclax | 1651890-44-6 | |
| ML141 | ML 141 | 71203-35-5 |
| Lisaftoclax | Bcl-2/Bcl-xl inhibitor 1 | 2180923-05-9 |
| CCT369260 | 化合物 CCT369260 | 2647503-57-7 |
| SD-36 | 2429877-44-9 | |
| MCL-1/BCL-2-IN-3 | 2163793-55-1 | |
| DCZ0415 | 2242470-43-3 | |
| Cobimetinib | 考比替尼 | 934660-93-2 |
| Cantrixil | 2135511-22-5 | |
| SKI-I | 化合物 SKI-I | 306301-68-8 |
| FB23-2 | 2243736-45-8 | |
| BCL6-IN-5 | 2253878-09-8 | |
| PFI-90 | N'-(吡啶-2-基)吡啶-2-甲酰肼 | 53995-62-3 |
| Maritoclax | Mcl-1抑制剂 | 1227962-62-0 |
| Palomid 529 | PALOMID 529 (P529) | 914913-88-5 |
| Rohinitib | 化合物 ROHINITIB | 1139253-73-8 |
| Cilengitide | 西仑吉肽 | 188968-51-6 |
| S55746 | 化合物S55746 | 1448584-12-0 |
| CLZ-8 | MCL1-IN-8 | 678158-55-9 |
| MPI-0479605 | N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 | 1246529-32-7 |
| Desmorpholinyl Navitoclax-NH-Me | 化合物DESMORPHOLINYL NAVITOCLAX-NH-ME | 2365172-82-1 |
| APG-1387 | 1570231-89-8 | |
| NSC 15364 | 1,3-二(4-氨基苯基)脲 | 4550-72-5 |
| Amiloride hydrochloride | 盐酸阿米洛利 | 2016-88-8 |
| Bosutinib hydrate | 博舒替尼一水化合物 | 918639-08-4 |
| Nilotinib-d6 | 尼罗替尼-D6 | 1268356-17-7 |
| Ponatinib-d8 | 纳替尼-D8 | 1562993-37-6 |
| DPH | 5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 | 484049-04-9 |
| S116836 | 化合物 T24751 | 1257628-57-1 |
| GMB-475 | 2490599-18-1 | |
| Rebastinib | N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 | 1020172-07-9 |
| JX06 | 4,4'-(dithiodicarbonothioyl)dimorpholine | 729-46-4 |
| A-1331852 | 1430844-80-6 | |
| Navitoclax-piperazine | ABT-263-piperazine | 2143096-93-7 |
| TCS7010 | Aurora A Inhibitor I | 1158838-45-9 |
| Vincristine-d3-ester (sulfate) | [2H3]-长春新碱硫酸盐 | 1217854-24-4 |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | 199807-33-5 | 199807-33-5 |
| Olverembatinib | 奥瑞巴替尼布 | 1257628-77-5 |
| Olverembatinib dimesylate | GZD824DIMESYLATE | 1421783-64-3 |
| Tributyrin | 三丁酸甘油酯 | 60-01-5 |
| Taltobulin | N,BETA,BETA-三甲基-L-苯基丙氨酰基-N-[(1S,2E)-3-羧基-1-(1-甲基乙基)-2-丁烯基]-N,3-二甲基-L-缬氨酰胺 | 228266-40-8 |
| KS106 | 化合物 KS106 | 2408477-50-7 |
| ARD-61 | 2316837-08-6 | |
| Z-Asp-CH2-DCB | CASPASE-1 INHIBITOR V ;Z-VAL-ALA-ASP(OME)-FLUOROMETHYLKETONE | 153088-73-4 |
| Takinib | 1111556-37-6 | 1111556-37-6 |
| LDN-57444 | 668467-91-2 | |
| Eprenetapopt | APR-246 | 5291-32-7 |
| Mirodenafil dihydrochloride | 米罗那非二盐酸盐 | 862189-96-6 |
| Flunisolide | 氟尼缩松 | 3385-03-3 |
| ASTX660 | 1799328-86-1 | |
| Ketoprofen-d3 | 酮洛芬D3 | 159490-55-8 |
| PDK4-IN-1 hydrochloride | 2310262-11-2 | |
| RRx-001 | 925206-65-1 | |
| Asciminib hydrochloride | 阿思尼布盐酸盐 | 2119669-71-3 |
| UMI-77 | 518303-20-3 | |
| MM-401 TFA | 化合物 MM-401 TFA | 1442106-11-7 |
| Perphenazine-d4 | 奋乃静D4 | 155593-75-2 |
| Mangafodipir trisodium | 锰福地吡三钠 | 140678-14-4 |
| 3BDO | 3BDO, MTOR激酶激活剂, 自噬抑制剂 | 890405-51-3 |
| (E)-Ferulic acid-d3 | 阿魏酸-D3 | 860605-59-0 |
| GNF-5 | 778277-15-9 | |
| PTC209 HBr | PTC-209HBR | 1217022-63-3 |
| BDP TMR NHS ester | BODIPYTMRNHS活化酯 | 485397-12-4 |
| Lys-[Des-Arg9]Bradykinin TFA | 化合物LYS-[DES-ARG9]BRADYKININ,TFA | 2763588-90-3 |
| Des-Arg9]-Bradykinin acetate | [DES-ARG9]-缓激肽 乙酸盐 水合物 | 23827-91-0 |
| Bradykinin (2-9) | 16875-11-9 | |
| Dihydrodiol-Ibrutinib | 依鲁替尼代谢物 | 1654820-87-7 |
| (±)-Zanubrutinib | (±)-赞鲁替尼 | 1633350-06-7 |
| BMS-986142 | BMS986142 | 1643368-58-4 |
| ARQ 531 | ARQ-531 | 2095393-15-8 |
| BTK inhibitor 10 | 2241732-30-7 | |
| (R)-Pirtobrutinib | 2101700-14-3 | |
| Branebrutinib | BMS-986195 | 1912445-55-6 |
| BODIPY564/570carboxylicacid | BODIPY564/570羧酸 | 150173-89-0 |
| BODIPYFLcarboxylicacid | BODIPYFL羧酸 | 165599-63-3 |
| BODIPYFLNHSester | BODIPYFLNHS活化酯 | 146616-66-2 |
| Bradykinin (1-5) | ARG-PRO-PRO-GLY-PHE | 23815-89-6 |
| Zanubrutinib | 泽布替尼 | 1691249-45-2 |
| Elacridar | 依克立达 | 143664-11-3 |
| BODIPYR6Gcarboxylicacid | BODIPYR6G羧酸 | 174881-57-3 |
| Btk inhibitor 2 | 1558036-85-3 | |
| SJF620 | 2376187-16-3 | |
| TL-895 | 2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-4-fluoro-1-piperidinyl]- | 1415823-49-2 |
| Bafetinib | 巴氟替尼 | 859212-16-1 |
| (S)-ML753286 | 1699720-85-8 | 1699720-85-8 |
| BODIPY558/568NHSester | BODIPY558/568NHS活化酯 | 150173-73-2 |
联系方式
